drug · small molecule
patient view →avatrombopag maleate
Marketedupdated 2mo agoby Swedish Orphan Biovitrum AB🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for thrombocytopenia and liver disease.
targets
Thrombopoietin receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that